|
|
Article: New drugs: health and economic impacts. (Research Summaries).
- Article from:
- NBER Reporter
- Article date:
- December 22, 2002
- Author:
CopyrightCOPYRIGHT 2002 National Bureau of Economic Research, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Many economists believe that new goods are at the heart of economic progress, and that innovative goods are better than older products because they provide more "product services" in relation to their cost of production. The pharmaceutical industry has among the highest propensities to generate new goods; it is one of the most R and D-intensive industries in the economy. Moreover, in part because of extensive FDA regulation, there is unusually good data about the launch and diffusion of new pharmaceutical goods. I have used these data to perform a number of econometric studies at the individual, disease, and country level, in order to assess the health and economic impacts ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA Rule on Export Requirements for Unapproved New ...
US Fed News Service, Including US State News;
January 21, 2006 ;
317 words
... ... Management Staff has transmitted, pursuant to law, the report of a rule entitled "Investigational New Drugs: Export Requirements for Unapproved New Drug Products." The document (RIN0910-AA61)(Docket No. 2000N-1663) was received by the ...
|
|